Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 15, 2005Clinical Cancer ResearchOpen Access

Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

RYRobert L. YauchGene Therapy LaboratoryTJThomas JanuarioRoche (United States)DEDavid A. EberhardUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yauch et al. (2005) studied this question.

synapsesocial.com/papers/6a0cf7e0216d108c6fcc9040https://doi.org/10.1158/1078-0432.ccr-05-1492
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?2005 · 671 citations
  2. 2Amplification and Enhanced Expression of the Epidermal Growth Factor Receptor Gene in A431 Human Carcinoma Cells1984 · 408 citations
  3. 3Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology2005 · 414 citations